Safety of botulinum toxin therapies.
Madalinski
Mariusz H
MH
Slawek
Jaroslaw
J
D001905:Botulinum Toxins / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000627:therapeutic use; D019274:Botulinum Toxins, Type A / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004351:Drug Resistance; D005401:Fissure in Ano / Q000188:drug therapy*; D006801:Humans; D045727:Metalloexopeptidases; D009465:Neuromuscular Agents / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000627:therapeutic use; D009566:Nitrates / Q000494:pharmacology / Q000627:therapeutic use
D009465:Neuromuscular Agents; D009566:Nitrates; C096323:rimabotulinumtoxinB; D045727:Metalloexopeptidases; D001905:Botulinum Toxins; D019274:Botulinum Toxins, Type A